Literature DB >> 26922326

Systemic lupus erythematosus: Is it one disease?

Francisco Rivas-Larrauri1, Marco Antonio Yamazaki-Nakashimada2.   

Abstract

Systemic lupus erythematosus (SLE) is a multisystemic disease with a variety of clinical presentations. Monogenic predisposing conditions to the development of this disease have been described. As examples, an impaired expression of interferon-α regulated genes or complement deficiencies have been reported in patients with SLE, with particular clinical presentations. Those defects present particular presentations and a different severity, making an argument that lupus is not a single disease but many. Treatment could be individualized depending on the underlying defect generating the subtype of the disease.
Copyright © 2016 Elsevier España, S.L.U. and Sociedad Española de Reumatología y Colegio Mexicano de Reumatología. All rights reserved.

Entities:  

Keywords:  Complement deficiency; Deficiencia de complemento; Inmunodeficiencia primaria; Interferonopathy; Interferonopatía; Lupus eritematoso sistémico; Primary immunodeficiency; Systemic lupus erythematosus

Mesh:

Substances:

Year:  2016        PMID: 26922326     DOI: 10.1016/j.reuma.2016.01.005

Source DB:  PubMed          Journal:  Reumatol Clin        ISSN: 1699-258X


  7 in total

1.  Variability of the rs333 in Polish patients with lupus erythematosus.

Authors:  Dominika Mlicka; Anna Duleba; Rafał Czajkowski; Mariusz Gawrych; Anna Woźniacka; Ewa Robak; Marta Gorzkiewicz; Szymon Kozłowski; Tomasz Grzybowski; Katarzyna Skonieczna
Journal:  Postepy Dermatol Alergol       Date:  2021-03-10       Impact factor: 1.837

Review 2.  DNA Damage and Deficiencies in the Mechanisms of Its Repair: Implications in the Pathogenesis of Systemic Lupus Erythematosus.

Authors:  Martha Paola Mireles-Canales; Susana Aideé González-Chávez; Celia Maria Quiñonez-Flores; Ever Adán León-López; César Pacheco-Tena
Journal:  J Immunol Res       Date:  2018-07-12       Impact factor: 4.818

3.  DNMT3B (rs2424913) polymorphism is associated with systemic lupus erythematosus alone and with co-existing periodontitis in a Brazilian population.

Authors:  Larissa Nadine da Silva Dias; Marina de Castro Coêlho; Darlene Camati Persuhn; Isabella Lima Arrais Ribeiro; Eutilia Andrade Medeiros Freire; Naila Francis Paulo de Oliveira; Sabrina Garcia de Aquino
Journal:  J Appl Oral Sci       Date:  2022-04-29       Impact factor: 3.144

4.  SLE classification criteria: Science-based icons or algorithmic distractions - an intellectually demanding dilemma.

Authors:  Ole Petter Rekvig
Journal:  Front Immunol       Date:  2022-09-28       Impact factor: 8.786

Review 5.  Human Pluripotent Stem-Cell-Derived Models as a Missing Link in Drug Discovery and Development.

Authors:  Xiying Lin; Jiayu Tang; Yan-Ru Lou
Journal:  Pharmaceuticals (Basel)       Date:  2021-05-30

6.  An Update on the Management of Childhood-Onset Systemic Lupus Erythematosus.

Authors:  Vitor Cavalcanti Trindade; Magda Carneiro-Sampaio; Eloisa Bonfa; Clovis Artur Silva
Journal:  Paediatr Drugs       Date:  2021-07-10       Impact factor: 3.022

7.  Effects of Gasdermin D in Modulating Murine Lupus and its Associated Organ Damage.

Authors:  Xinghao Wang; Luz P Blanco; Carmelo Carmona-Rivera; Shuichiro Nakabo; Hege L Pedersen; Zu-Xi Yu; Mariana J Kaplan
Journal:  Arthritis Rheumatol       Date:  2020-10-17       Impact factor: 15.483

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.